Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK

PHASE3CompletedINTERVENTIONAL
Enrollment

255

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Gastric Cancer
Interventions
DRUG

Tegafur-gimeracil-oteracil potassium (TS-1)

From 4-8 weeks after surgery to 27-31 weeks after surgery, 80 mg/m2, PO from day 1 to day 14 of each 21 day cycle. Number of Cycles: 8 From 28-32 weeks after surgery to 53-57 weeks after surgery, 80 mg/m2, PO from day 1 to day 14 of each 28 day cycle. Number of Cycles: 7

DRUG

Krestin (PSK)

From 4-8 weeks after surgery to 53-57 weeks after surgery, 3 g/day, PO every day

Trial Locations (42)

910-0833

Fukui Cardio Vascular Center, Fukui-shi

910-8561

Fukui General Hospital, Fukui-shi

918-8503

Fukui Saiseikai Hospital, Fukui-shi

910-1193

University of Fukui Hospital, Iijima

914-0195

National Hospital Organization Fukui Hospital, Tsuruga

500-8513

Gifu Municipal Hospital, Gifu

500-8717

Gifu Prefectural General Medical Center, Gifu

501-1194

Gifu University Hospital, Gifu

651-1145

Shakaihoken Kobe Central Hospital, Kobe

924-8588

Public Central Hospital of Matto Ishikawa, Hakusan

920-0934

Kanazawa University Hospital, Kanazawa

920-8530

Ishikawa Prefectural Central Hospital, Kanazawa

921-8162

Kanazawa Redcross Hospital, Kanazawa

920-0293

Kanazawa Medical University Hospital, Mukai-awagasaki

620-8505

Fukuchiyama City Hospital, Fukuchiyama

612-8364

Kyoto Ohashi General Hospital, Fushimi

610-0121

Houyu hospital, Jōyō

617-0814

Saiseikai Kyoto Hospital, Kōtari

602-8566

University Hospital, Kyoto Prefectural University of Medicine, Kyoto

602-8800

Nishijin Hospital, Kyoto

605-0981

Kyoto First Red Cross Hospital, Kyoto

625-8502

National Hospital Organization Maizuru Medical Center, Maizuru

629-0197

Nantan General Hospital, Nantan

611-0001

Rokujizo Hospital, Uji

611-0025

Second Okamoto General Hospital, Uji

629-2261

Kyoto Prefectural Yosanoumi Hospital, Yotsutsuji

604-8405

Marutamachi Hospital, Nishinokyokurumazaka-cho

630-8305

Nara City Hospital, Nara

570-8540

Matsushita Memorial Hospital, Moriguchi

545-0053

Osaka Railway hospital, Osaka

569-1121

Midorigaoka Hospital, Takatsuki

545-8586

Osaka City University Hospital, Kembuchi

530-0005

Sumitomo Hospital, Nakanoshima

520-2192

Shiga University of Medical Science Hospital, Ōtsu

520-3040

Saiseikai Shigaken Hospital, Rittō

693-8501

Shimane University Hospital, Izumo

933-8525

Saiseikai Takaoka Hospital, Takaoka

933-8555

Kouseiren Takaoka Hoapital, Takaoka

930-8550

Toyama Prefectural Central Hospital, Toyama

937-0042

Toyama Rosai Hospital, Uozu

939-2376

Yatsuo General Hospital, Yatsuomachi-higashikumisaka

644-0011

Kitade Hospital, Gobou

All Listed Sponsors
lead

Hokuriku-Kinki Immunochemotherapy Study Group

OTHER

NCT00216034 - Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK | Biotech Hunter | Biotech Hunter